echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Coronavirus is not a virus that can be embedded in the human genome

    Coronavirus is not a virus that can be embedded in the human genome

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
















    Russian expert: Coronavirus is not a virus that can be embedded in the human genome




    Russian expert: Coronavirus is not a virus that can be embedded in the human genome Russian expert: Coronavirus is not a virus that can be embedded in the human genome

     

    Dong Yingbi, Russian Correspondent, Science and Technology Daily

    Recently, a "vector" of Virology and Biotechnology, National Science Center Yekaterinburg Division Acting Director of the Russian consumer protection and public supervision bureau belongs • Alexander Semenov said that the AIDS virus or different hepatitis B virus, coronavirus may not belong Viruses embedded in the human genome have no genes encoding proteins to cut human DNA and insert the virus into chromosomes; coronaviruses are constantly mutating, and the mutation process is developing in the direction of increasing infectivity.
    Each mutant strain is more The previous ones are more contagious and aggressive, this is the law of natural selection

    .

    AIDS

    Semenov said that the representative of the coronavirus, the Coronavirus family, does not have the necessary structure to integrate with the human genome and to artificially interfere with it
    .
    Nature does exist can be inserted into the human genome viruses, such as scientists have long conducted studies
    of AIDS drugs, hepatitis B virus, a variety of tumor viruses
    .
    But the coronavirus family cannot be embedded in the genome at all.
    They have no genes encoding proteins to cut human DNA and insert viruses into chromosomes

    .

    AIDS

    Semenov believes that the coronavirus is constantly mutating, and the mutation process is developing in the direction of increasing infectivity.
    Each mutated strain is more infectious and aggressive than the previous ones.
    This is the law of natural selection

    .
    For example, the third wave of the epidemic caused by the delta mutant strain is obviously more contagious than the original new coronavirus, alpha mutant strain, and beta mutant strain.
    It has spread to all parts of the world and replaced other mutant strains of the new crown virus

    .
    Many experts in the world also believe that the characteristics of Delta are significantly different from other mutant strains.
    From the point of infection, it is developing in a "worse" direction

    .

    Alexander Semenov said that due to some mutations in the Delta virus genome, it is more suitable to penetrate human cells, reproduce faster, attack more tissues including lung tissue, and is also infectious to young people.

    .
    Patients infected with delta virus base have symptoms more like acute respiratory virus infection, runny nose, sore throat, coughing and sneezing

    .
    Because it penetrates the larynx epithelium into the lungs faster, the clinical development of pneumonia is faster

    .
    The incubation period of the new coronavirus is 7-11 days, while the delta mutant virus only needs 3-5 days

    .
    All these symptoms also indicate that the new coronavirus comes from nature like the flu

    .

    Semenov is a well-known Russian virologist.
    He used to be the deputy director of the St.
    Petersburg Pasteur Institute of Epidemiology and Microbiology.
    Due to his outstanding work, he was transferred to the "vector" virus of the Russian Consumer Rights Protection and Public Welfare Supervision Agency this year.
    Acting Director of Yekaterinburg Branch of the National Science Center for Science and Biotechnology

    .
    In recent years, he has been actively studying the world's experience in fighting the most dangerous diseases

    .
    From 2014 to 2015, he participated in the Russian medical team expedition to Africa to help fight the Ebola virus

    .
    Since the start of the global new crown epidemic, he has been introducing the situation and related issues of the new crown virus from a scientific point of view

    .

    The Russian "Vector" National Science Center for Virology and Biotechnology is a world-renowned virology research institution
    .
    The center keeps samples of high-risk viruses including smallpox, Ebola, and SARS.
    There are only two similar laboratories in the world (the other one is in the United States)

    .
    The center first developed a new coronavirus test agent in Russia in March 2020; in November it developed Russia’s second new coronavirus vaccine EpiVacCorona, which is a synthetic vaccine and has been used for mass vaccination in Russia; currently the center is developing Nasal spray of new crown vaccine

    .
    (Our newspaper, Moscow, July 26th)

    Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.